And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

ASMB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.10%

Insider Buying (Last 12 Months): $233,990.64

Insider Selling (Last 12 Months): $101,200.22

Assembly Biosciences Insider Trading History Chart

Assembly Biosciences Share Price & Price History

^$12.95

▲ +0.33 (2.61%)

As of 05/8/2024 01:00 AM ET

Days: 30 | 90 | 365

Dems have chosen Biden replacement?

From Paradigm Press | Ad

On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.

See who it is HERE.

Assembly Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/30/2024	Jason A Okazaki	CEO	Sell	1,569	$12.71	$19,941.99	16,423
4/30/2024	Nicole S White	Insider	Sell	1,255	$12.71	$15,951.05	13,025
4/1/2024	Jason A Okazaki	CEO	Sell	354	$13.07	$4,626.78	13,826
4/1/2024	Jeanette M Bjorkquist	Insider	Sell	114	$13.07	$1,489.98	3,166
4/1/2024	John G. McHutchison	Director	Sell	1,206	$13.07	$15,762.42	21,221
3/27/2024	Jason A Okazaki	CEO	Sell	392	$12.87	$5,045.04	14,180
1/17/2024	Alexander Schornstein	Major Shareholder	Buy	24,999	$9.36	$233,990.64	655,357
10/3/2023	Jason A Okazaki	CEO	Sell	196	$9.60	$1,881.60	14,576
10/3/2023	Nicole S White	Insider	Sell	157	$9.60	$1,507.20	7,854
7/24/2023	Jeanette M Bjorkquist	Insider	Sell	70	$12.84	$898.80	2,224
5/23/2023	Jason A Okazaki	CEO	Sell	546	$12.48	$6,814.08	10,551
5/23/2023	Jeanette M Bjorkquist	Insider	Sell	22	$12.48	$274.56	2,294
5/23/2023	John G. McHutchison	Director	Sell	2,164	$12.48	$27,006.72	14,096
3/30/2023	Jason A Okazaki	CEO	Sell	353	$9.84	$3,473.52	8,181
3/30/2023	Jeanette M Bjorkquist	Insider	Sell	64	$9.84	$629.76	1,983
3/30/2023	John G. McHutchison	Director	Sell	1,240	$9.84	$12,201.60	14,802
3/27/2023	Jason A Okazaki	CEO	Sell	391	$12.24	$4,785.84	8,535
8/8/2022	John G. McHutchison	CEO	Sell	1,026	$25.56	$26,224.56	16,042
7/25/2022	Michael P Samar	CFO	Sell	168	$26.64	$4,475.52	6,435
5/31/2022	William E Iv Delaney	Insider	Sell	347	$23.04	$7,994.88	6,368
3/30/2022	Jason A Okazaki	COO	Sell	105	$26.04	$2,734.20
3/30/2022	John G. McHutchison	CEO	Sell	384	$26.04	$9,999.36
3/30/2022	Luisa M Stamm	Insider	Sell	86	$26.04	$2,239.44
3/30/2022	Michael P Samar	CFO	Sell	190	$26.04	$4,947.60
3/28/2022	Jason A Okazaki	COO	Sell	384	$26.88	$10,321.92
8/9/2021	John G. McHutchison	CEO	Sell	1,013	$43.20	$43,761.60
5/27/2021	William E. lv Delaney	Insider	Sell	344	$48.36	$16,635.84

Elon to Transform U.S. Economy?

From Porter & Company | Ad

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

SEC Filings (Institutional Ownership Changes) for Assembly Biosciences (NASDAQ:ASMB)

19.92% of Assembly Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Assembly Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/7/2024	Marquette Asset Management LLC	9,016	$0.12M	0.0%	-83.4%	0.165%
2/2/2024	Marquette Asset Management LLC	54,464	$45K	0.0%	N/A	0.083%
2/2/2024	Acuitas Investments LLC	265,585	$0.22M	0.1%	N/A	0.404%
1/31/2024	Federated Hermes Inc.	304,735	$0.25M	0.0%	-10.9%	0.463%
12/7/2023	Hudson Bay Capital Management LP	199,789	$0.18M	0.0%	-75.8%	0.304%
11/13/2023	Acadian Asset Management LLC	83,470	$73K	0.0%	-26.7%	0.127%
8/7/2023	Acadian Asset Management LLC	113,854	$0.13M	0.0%	-27.7%	0.218%
5/12/2023	Platinum Investment Management Ltd.	890,736	$0.75M	0.0%	-18.6%	1.709%
5/8/2023	Federated Hermes Inc.	363,023	$0.31M	0.0%	-2.8%	0.699%
2/14/2023	Susquehanna International Group LLP	21,255	$28K	0.0%	-37.7%	0.044%
2/13/2023	Platinum Investment Management Ltd.	1,094,770	$1.42M	0.1%	-24.5%	2.244%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	65,393	$85K	0.0%	-49.6%	0.134%
11/15/2022	Platinum Investment Management Ltd.	1,450,328	$2.38M	0.1%	-8.9%	2.973%
11/14/2022	Healthcare of Ontario Pension Plan Trust Fund	570,300	$0.94M	0.0%	N/A	1.169%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	129,752	$0.21M	0.0%	-9.2%	0.268%
11/7/2022	Virtu Financial LLC	30,046	$49K	0.0%	N/A	0.062%
11/3/2022	Barclays PLC	37,194	$61K	0.0%	-76.9%	0.077%
10/27/2022	Assenagon Asset Management S.A.	253,783	$0.42M	0.0%	-62.9%	0.524%
9/16/2022	Federated Hermes Inc.	373,665	$0.79M	0.0%	-2.0%	0.771%
8/11/2022	Platinum Investment Management Ltd.	1,591,272	$3.34M	0.1%	-16.7%	3.300%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	142,915	$0.30M	0.0%	-13.4%	0.296%
7/27/2022	Assenagon Asset Management S.A.	684,846	$1.44M	0.0%	+1,422.3%	1.420%
7/19/2022	Commonwealth Equity Services LLC	25,749	$54K	0.0%	+30.4%	0.053%
5/16/2022	Eversept Partners LP	280,000	$0.58M	0.0%	-9.7%	0.582%
5/12/2022	Acadian Asset Management LLC	927,402	$1.91M	0.0%	-42.4%	1.927%
5/11/2022	GSA Capital Partners LLP	135,834	$0.28M	0.0%	N/A	0.282%
4/26/2022	Marquette Asset Management LLC	58,246	$0.12M	0.0%	+21.3%	0.121%
4/25/2022	Assenagon Asset Management S.A.	44,987	$93K	0.0%	N/A	0.093%
2/14/2022	Deep Track Capital LP	3,000,000	$6.99M	0.5%	N/A	6.268%
2/14/2022	Eversept Partners LP	310,000	$0.72M	0.1%	-11.4%	0.648%
2/10/2022	Candriam Luxembourg S.C.A.	1,838,221	$4.28M	0.0%	+25.1%	3.841%
2/10/2022	Acadian Asset Management LLC	1,608,760	$3.75M	0.0%	+13.9%	3.361%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	170,216	$0.40M	0.0%	+8.8%	0.356%
2/9/2022	Dimensional Fund Advisors LP	553,428	$1.29M	0.0%	+54.0%	1.156%
1/21/2022	Russell Investments Group Ltd.	123,748	$0.29M	0.0%	+41.2%	0.259%
1/19/2022	Marquette Asset Management LLC	48,000	$0.11M	0.0%	+73.7%	0.100%
12/29/2021	Hudson Bay Capital Management LP	850,000	$2.96M	0.0%	+13.3%	1.776%
11/16/2021	Two Sigma Advisers LP	348,700	$1.21M	0.0%	-53.9%	0.729%
11/15/2021	Hudson Bay Capital Management LP	850,000	$2.96M	0.0%	+13.3%	1.776%
11/15/2021	Eversept Partners LP	350,000	$1.22M	0.1%	N/A	0.731%
11/15/2021	Dimensional Fund Advisors LP	359,315	$1.25M	0.0%	-23.4%	0.751%
11/15/2021	Franklin Resources Inc.	584,688	$2.04M	0.0%	+10.6%	1.222%
11/12/2021	Renaissance Technologies LLC	130,600	$0.45M	0.0%	-63.3%	0.273%
11/12/2021	Prosight Management LP	265,634	$0.92M	0.5%	+78.2%	0.555%
11/12/2021	Geode Capital Management LLC	525,263	$1.83M	0.0%	+11.2%	1.097%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	156,415	$0.54M	0.0%	+3.1%	0.327%
11/10/2021	Goldman Sachs Group Inc.	131,367	$0.46M	0.0%	-30.8%	0.292%
11/10/2021	IndexIQ Advisors LLC	97,739	$0.34M	0.0%	+11.1%	0.204%
11/9/2021	Barclays PLC	212,980	$0.74M	0.0%	+31.3%	0.445%
11/9/2021	BlackRock Inc.	1,969,977	$6.86M	0.0%	+3.0%	4.116%
11/9/2021	Candriam Luxembourg S.C.A.	1,468,846	$5.11M	0.0%	+31.9%	3.069%
11/8/2021	Russell Investments Group Ltd.	87,636	$0.30M	0.0%	+72.7%	0.195%
10/12/2021	Marquette Asset Management LLC	27,641	$96K	0.0%	+21.8%	0.061%
9/17/2021	Virtu Financial LLC	64,020	$0.25M	0.0%	N/A	0.142%
9/3/2021	Parametric Portfolio Associates LLC	89,340	$0.35M	0.0%	+106.5%	0.199%
8/17/2021	Raffles Associates LP	100,000	$0.39M	0.3%	+100.0%	0.222%
8/17/2021	Millennium Management LLC	532,327	$2.07M	0.0%	+510.2%	1.184%
8/17/2021	Armistice Capital LLC	2,224,000	$8.63M	0.2%	-0.5%	4.945%
8/17/2021	Boothbay Fund Management LLC	21,145	$82K	0.0%	+74.2%	0.047%
8/17/2021	Bridgeway Capital Management LLC	64,000	$0.25M	0.0%	-57.3%	0.142%
8/16/2021	SG3 Management LLC	10,000	$39K	0.0%	N/A	0.022%
8/16/2021	LMR Partners LLP	14,225	$55K	0.0%	N/A	0.032%
8/16/2021	Cubist Systematic Strategies LLC	33,277	$0.13M	0.0%	-45.4%	0.074%
8/16/2021	Occudo Quantitative Strategies LP	89,502	$0.35M	0.1%	-7.9%	0.199%
8/16/2021	New York Life Investments Alternatives	11,324	$44K	0.0%	N/A	0.025%
8/16/2021	Charles Schwab Investment Management Inc.	194,046	$0.75M	0.0%	-12.9%	0.431%
8/16/2021	State Street Corp	170,423	$0.66M	0.0%	-72.2%	0.379%
8/16/2021	Tibra Equities Europe Ltd	72,700	$0.28M	0.1%	N/A	0.162%
8/16/2021	Federated Hermes Inc.	523,682	$2.03M	0.0%	+15,588.5%	1.164%
8/16/2021	Goldman Sachs Group Inc.	189,721	$0.74M	0.0%	+18.9%	0.422%
8/13/2021	Renaissance Technologies LLC	355,841	$1.38M	0.0%	-38.4%	0.791%
8/13/2021	Northern Trust Corp	102,163	$0.40M	0.0%	-72.5%	0.227%
8/13/2021	Franklin Resources Inc.	528,688	$2.05M	0.0%	-41.9%	1.176%
8/13/2021	Geode Capital Management LLC	472,303	$1.83M	0.0%	-28.1%	1.050%
8/13/2021	Vanguard Group Inc.	1,883,644	$7.31M	0.0%	-6.1%	4.188%
8/12/2021	Vida Ventures Advisors LLC	384,635	$1.49M	0.4%	-14.5%	0.855%
8/12/2021	Dimensional Fund Advisors LP	469,193	$1.82M	0.0%	-5.7%	1.043%
8/12/2021	JPMorgan Chase & Co.	55,522	$0.22M	0.0%	-80.2%	0.123%
8/12/2021	Ergoteles LLC	108,600	$0.42M	0.0%	N/A	0.241%
8/12/2021	Connor Clark & Lunn Investment Management Ltd.	151,677	$0.59M	0.0%	+9.3%	0.337%
8/12/2021	Bridgefront Capital LLC	11,503	$45K	0.0%	N/A	0.026%
8/11/2021	Bank of New York Mellon Corp	22,996	$90K	0.0%	-81.8%	0.051%
8/11/2021	BlackRock Inc.	1,912,094	$7.42M	0.0%	-41.9%	4.252%
8/6/2021	Sei Investments Co.	32,619	$0.12M	0.0%	-30.1%	0.081%
8/4/2021	Russell Investments Group Ltd.	50,732	$0.20M	0.0%	-61.7%	0.126%
8/2/2021	Pinnacle Wealth Planning Services Inc.	10,839	$42K	0.0%	N/A	0.027%
7/19/2021	Marquette Asset Management LLC	22,691	$88K	0.0%	N/A	0.057%
5/19/2021	Squarepoint Ops LLC	34,600	$0.16M	0.0%	-21.8%	0.086%
5/18/2021	Millennium Management LLC	87,237	$0.40M	0.0%	N/A	0.217%
5/18/2021	Cubist Systematic Strategies LLC	60,925	$0.28M	0.0%	-51.7%	0.152%
5/18/2021	Man Group plc	49,800	$0.23M	0.0%	-70.2%	0.124%
5/17/2021	PDT Partners LLC	274,476	$1.26M	0.1%	+734.3%	0.683%
5/17/2021	AQR Capital Management LLC	58,444	$0.27M	0.0%	-40.7%	0.146%
5/17/2021	Armistice Capital LLC	2,236,000	$10.29M	0.2%	-14.8%	5.568%
5/17/2021	Walleye Trading LLC	33,266	$0.15M	0.0%	-22.5%	0.083%
5/17/2021	Walleye Capital LLC	80,524	$0.37M	0.0%	-20.1%	0.201%
5/17/2021	Ameriprise Financial Inc.	16,960	$78K	0.0%	+50.5%	0.042%
5/17/2021	HRT Financial LP	31,480	$0.14M	0.0%	+9.5%	0.078%
5/17/2021	Goldman Sachs Group Inc.	159,581	$0.73M	0.0%	+33.3%	0.397%
5/14/2021	Prosight Management LP	56,500	$0.26M	0.2%	N/A	0.141%

Data available starting January 2016

Assembly Biosciences, Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's next-generation HBV core inhibitors include ABI-4334, which is in Phase 1a studies for the treatment of HBV; and ABI-H3733, which is in Phase 1b clinical study. It is also involved in novel small molecule approaches for HBV and hepatitis delta virus (HDV) comprising an orally bioavailable HBV/HDV entry inhibitor and liver-focused interferon-a receptor agonist. In addition, the company develops Herpesvirus programs, such as ABI-5366 HSV-2, a long-acting helicase inhibitor; and pan-herpes non-nucleoside polymerase inhibitors for transplant-associated infections. Further, Assembly Biosciences, Inc. has collaboration agreement with BeiGene, Ltd. to develop and commercialize the novel core inhibitor product candidates for chronic HBV infection in the People's Republic of China, Hong Kong, Taiwan, and Macau; and clinical trial collaboration agreement with Arbutus Biopharma Corporation to conduct a randomized, multi-center, and open-label clinical trials, as well as agreement with Antios Therapeutics, Inc. for triple combination therapy. The company also has license agreement with Indiana University Research and Technology Corporation for HBV research, as well as a partnership with Gilead Sciences, Inc. to develop next-generation therapeutics for serious viral diseases. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Today's Range

Now: $12.95

$12.51

$13.05

50 Day Range

MA: $13.26

$11.80

$15.06

52 Week Range

Now: $12.95

$7.69

$20.04

Volume

13,958 shs

Average Volume

25,959 shs

Market Capitalization

$71.00 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.6

Who are the company insiders with the largest holdings of Assembly Biosciences?: Assembly Biosciences' top insider investors include:
Alexander Schornstein (Major Shareholder)
John G Mchutchison (Director)
Jason A Okazaki (CEO)
John G Mchutchison (CEO)
Nicole S White (Insider)
Michael P Samar (CFO)
William E Iv Delaney (Insider)
Jeanette M Bjorkquist (Insider)
Learn More about top insider investors at Assembly Biosciences.
Who are the major institutional investors of Assembly Biosciences?: Assembly Biosciences' top institutional shareholders include:
Marquette Asset Management LLC — 0.16%
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Assembly Biosciences stock.
Which major investors are selling Assembly Biosciences stock?: Within the previous quarter, ASMB stock was sold by these institutional investors:
Marquette Asset Management LLC
In the previous year, company insiders that have sold Assembly Biosciences company stock include:
Alexander Schornstein (Major Shareholder)
John G Mchutchison (Director)
Jason A Okazaki (CEO)
John G Mchutchison (CEO)
Learn More investors selling Assembly Biosciences stock.

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

>> Register right here